JCM, Vol. 12, Pages 6929: Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus

JCM, Vol. 12, Pages 6929: Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus

Journal of Clinical Medicine doi: 10.3390/jcm12216929

Authors: Sameer Al Awadhi Mohamed Alboraie Emad Aldin Albaba Abdulelah Almutairdi Monther Alsaad Nahla Azzam Husam Barakat Ferdinando D’Amico Silvio Danese Mohamed El Kady Hossam Ghoneim Waseem Hamoudi Ahmad Jazzar Mahmoud Mosli Hany Shehab Awni Abu Sneineh

The prevalence of ulcerative colitis (UC) in the Middle East is increasing, impacting the economic and healthcare burden. The management of patients with mild to moderate UC is still a challenge as several factors can affect optimal care, including drug choice, induction and maintenance dose, treatment optimization and de-escalation, therapy duration, monitoring, and safety profile. We conducted an expert consensus to standardize the management of patients with mild to moderate UC. Sixteen experts in inflammatory bowel diseases, through a well-established and accepted Delphi methodology, voted and approved eight statements in order to provide practical guidance to clinicians in the Middle East.